Michele Malagola

28PUBLICATIONS
110CO-AUTHORS
Epidemiological modellingPredictive and prognostic markersCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 05, 2026
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo).

|Jul 02, 2026
Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

|Jun 26, 2026
Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. Cancers 2025, 17, 3278.

|Jun 24, 2026
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission.

|May 26, 2026
Humoral and Cellular Immune Response in Patients with Hematological Disorders After Three Doses of mRNA COVID-19 Vaccine: A Single-Center Observational Study.

|Jan 07, 2026
Human cytomegalovirus-specific T-cell responses and immune-guided strategies as predictors of clinically significant infection in hematopoietic stem cell transplant recipients after letermovir prophylaxis.

Dalila Mele, Michele Malagola, Federica Zavaglio

Pageof 5

Frequent Collaborators

17 joint publications

Polverelli Nicola

11 joint publications

Mirko Farina

10 joint publications

Simona Bernardi

7 joint publications

Massimo Martino